Opportunity ID: 335593

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-040
Funding Opportunity Title: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 08, 2021
Last Updated Date: Jan 11, 2024
Original Closing Date for Applications: Feb 15, 2024
Current Closing Date for Applications: Aug 02, 2024
Archive Date: Sep 01, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
State governments
City or township governments
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Independent school districts
Public and State controlled institutions of higher education
County governments
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date
updated expiration date as per NOT-DA-23-041 Jan 11, 2024
Sep 08, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-040
Funding Opportunity Title: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Sep 08, 2021
Last Updated Date: Jan 11, 2024
Original Closing Date for Applications: Feb 15, 2024
Current Closing Date for Applications: Aug 02, 2024
Archive Date: Sep 01, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
State governments
City or township governments
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Independent school districts
Public and State controlled institutions of higher education
County governments
Small businesses
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-22-040
Funding Opportunity Title: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 08, 2021
Last Updated Date: Sep 08, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Feb 15, 2024
Archive Date: Mar 22, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
County governments
Private institutions of higher education
Public housing authorities/Indian housing authorities
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-040.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Folder 335593 Full Announcement-RFA-DA-22-040 -> RFA-DA-22-040-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00269860 Jan 15, 2022 Jan 24, 2023 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00268873 Jan 15, 2022 Jan 24, 2022 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277847 Nov 01, 2022 Aug 02, 2024 View

Package 1

Mandatory forms

335593 RR_SF424_5_0-5.0.pdf

335593 PHS398_CoverPageSupplement_5_0-5.0.pdf

335593 RR_OtherProjectInfo_1_4-1.4.pdf

335593 PerformanceSite_4_0-4.0.pdf

335593 RR_KeyPersonExpanded_4_0-4.0.pdf

335593 PHS398_ResearchPlan_4_0-4.0.pdf

335593 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335593 RR_Budget_3_0-3.0.pdf

335593 RR_SubawardBudget30_3_0-3.0.pdf

335593 PHS398_ModularBudget_1_2-1.2.pdf

335593 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

335593 RR_SF424_2_0-2.0.pdf

335593 PHS398_CoverPageSupplement_5_0-5.0.pdf

335593 RR_OtherProjectInfo_1_4-1.4.pdf

335593 PerformanceSite_2_0-2.0.pdf

335593 RR_KeyPersonExpanded_2_0-2.0.pdf

335593 PHS398_ResearchPlan_4_0-4.0.pdf

335593 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

335593 RR_Budget_1_4-1.4.pdf

335593 RR_SubawardBudget30_1_4-1.4.pdf

335593 PHS398_ModularBudget_1_2-1.2.pdf

335593 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

335593 RR_SF424_5_0-5.0.pdf

335593 PHS398_CoverPageSupplement_5_0-5.0.pdf

335593 RR_OtherProjectInfo_1_4-1.4.pdf

335593 PerformanceSite_4_0-4.0.pdf

335593 RR_KeyPersonExpanded_4_0-4.0.pdf

335593 PHS398_ResearchPlan_5_0-5.0.pdf

335593 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335593 RR_Budget_3_0-3.0.pdf

335593 RR_SubawardBudget30_3_0-3.0.pdf

335593 PHS398_ModularBudget_1_2-1.2.pdf

335593 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T02:33:30-05:00

Share This Post, Choose Your Platform!

About the Author: